Persistent pulmonary arterial hypertension of the new born

  • A. Narang
  • O. N. Bhakoo
  • P. M. C. Nair
  • Vineet Bhandari
Original Articles


Persistent pulmonary hypertension of the newborn (PPHN) characterised by right to left shunting with intense cyanosis is difficult to manage, and in the best of centres carries a 40–60 percent mortality. We report our one year's experience of managing six neonates with PPHN.

There were 5 males and 1 female with mean birth weight of 2.59±0.487 kg and gestation period 39±2.0 wks and 1 minute Apgar score 2.8±2.1. Four to six babies were born by cesarean section and 3–6 babies had aspiration pneumonia. All babies presented within 12 hours of age (mean 5.08±5 hrs) with intense cyanosis and respiratory distress. Diagnosis were confirmed in all by (a) hyperoxia test, (b) simultaneous determination of preductal and postductal paO2 (c) contrast echocardiography and (d) hyperoxia-hyperventilation test. Babies were managed with hyperventilation using mean ventilatory rates of 100±45 per minute, an inspired oxygen concentration of 100%, peak inspiratory pressures 27±9 cm of H2O, and expiratory pressures 5±1.6 cms of H2O, and mean air way pressures of 10.4±2.7 cms H2O. Alkali therapy was used in 3 of the six babies whereas low dose dopamine was infused in all six babies. Inspite of aggressive ventilatory therapy, only 3 out of 6 babies could be salvaged.

Key words

Persistent pulmonary hypertension Hyperventilation 


  1. 1.
    Henry GW. Noninvasive assessment of cardiac function and pulmonary hypertension in PPHN.Clin Perinatol 1984; 11: 627–640.PubMedGoogle Scholar
  2. 2.
    Geggel RL, Reid LM. The structural basis of PPHN.Clin Perinatol 1984; 11: 525–549.PubMedGoogle Scholar
  3. 3.
    Fox WW. Mechanical ventilation in the management of PPHN. In:Proceedings of the 83rd Ross Conference on Cardiovascular Sequelae of Asphyxia in the Newborn 1982; pp. 102.Google Scholar
  4. 4.
    Peckham GH, Fox WW. Physiologic factors affecting pulmonary artery pressure in infants with persistent pulmonary hypertension.J Pediatr 1978; 93: 1005–1010.PubMedCrossRefGoogle Scholar
  5. 5.
    Fox WW, Gewitz MH, Sinwiddie R et al. Pulmonary hypertension in perinatal aspiration syndrome.Pediatrics 1977; 59: 205–208.PubMedGoogle Scholar
  6. 6.
    Drummond WH, Gregory GA, Heyman MA et al. The independent effects of hyperventilation, tolazoline and dopamine on infants with persistent pulmonary hypertension.J Pediatr 1981; 98: 603–611.PubMedCrossRefGoogle Scholar
  7. 7.
    Shutack JG, Moomjian AS, Fox WW et al. Severe obstructive airway disease associated with pulmonary artery hypertension in the neonate.Pediatric Res 1979; 13: 541–543.Google Scholar
  8. 8.
    Gersony WM. Persistence of the fetal circulation: A commentary.J Pediatr 1973; 82: 1103.PubMedCrossRefGoogle Scholar
  9. 9.
    Bloss RS, Turmen T, Beardmore HE et al. Tolazoline therapy for persistent pulmonary hypertension after congential diaphragmatic hernia repair.J Pediatr 1980; 97: 984–986.PubMedCrossRefGoogle Scholar
  10. 10.
    Morrow WR, Haas JE, Benjamin DR. Nonbacterial endocardial thrombosis in neonates: Relationship to persistent fetal circulation.J Pediatr 1982; 100: 117–119.PubMedCrossRefGoogle Scholar
  11. 11.
    Swischuck LE, Richardson CJ, Nichols MM et al. Primary pulmonary hypoplasia in the neonates.J Pediatr 1979; 95: 573–577.CrossRefGoogle Scholar
  12. 12.
    Drummond WH, Peckham GJ, Fox WW. The clinical profile of the newborn with persistent pulmonary, hypertension. Observations in 19 affected neonates.Clin Pediatr 1977; 16: 335–340.CrossRefGoogle Scholar
  13. 13.
    Fox WW, Duara S. Persistent pulmonary hypertension of the neonate: Diagnosis and clinical management.J Pediatr 1983; 103: 505–514.PubMedCrossRefGoogle Scholar
  14. 14.
    Duara S, Gewitz MH, Fox WW. Use of mechanical ventilation for clinical management of PPHN.Clin Perinatol 1984; 11: 641–652.PubMedGoogle Scholar
  15. 15.
    Valdes-Cruz LM, Dudell GG, Ferrara A. Utility of M-mode echocardiography for early identification of infants with PPHN.Pediatrics 1981; 68: 515–518.PubMedGoogle Scholar
  16. 16.
    Wung JT, James LS, Kilchersky E et al. Management of infants with severe respiratory failure and persistence of fetal circulation without hyperventilation.Pediatrics 1985; 76: 488–494.PubMedGoogle Scholar
  17. 17.
    Dworetz AR, Gladstone IM, Moya FR et al. Survival of infants with severe perisistent pulmonary hypertension (PPH) without extra corporeal membranes oxygenation-an update.Pediatr Res 1989; 25: 214A, Abstract No. 1260.CrossRefGoogle Scholar
  18. 18.
    Rosenbaum J, Barrios P, Canter C et al. Is hyperventilation appropriate therapy for all infants with PPHN?Pediatr Res 1989; 25: 229A, Abstract No. 1356.Google Scholar
  19. 19.
    Drummond WH, Lock JE. Neonatal pulmonary vasodilation drugs. Current status.Der Pharmacol Ther 1984; 7: 1–20.Google Scholar
  20. 20.
    Stevenson DK, Kasting DS, Durnall RA et al. Refractory hypoxemia associated with neonatal pulmonary disease, the use and limitations of tolazoline.J Pediatr 1979; 95: 595–599.PubMedCrossRefGoogle Scholar
  21. 21.
    Drummond WH. Cardiotonic therapy in management of PPHN.Clin Perinatol 1984; 11: 715–728.PubMedGoogle Scholar
  22. 22.
    Kulik TJ, Lock JE. Pulmonary vasodilator therapy in PPHN.Clin Perinatol 1984; 11: 693–701.PubMedGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 1992

Authors and Affiliations

  • A. Narang
    • 1
  • O. N. Bhakoo
    • 1
  • P. M. C. Nair
    • 1
  • Vineet Bhandari
    • 1
  1. 1.Neonatal Division of the Department of PediatricsPostgraduate Institute of Medical Education & ResearchChandigarh

Personalised recommendations